Skip to main content

Tower Research Capital LLC (TRC)

Position in NBIX — Neurocrine Biosciences Inc

CIK 1533421 NEW YORK, NY

Position in NBIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,225,285
+$689,104 QoQ
Shares Held
7,270
+78.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#373
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
7,270 $1,225,285

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,225,285 7,270
2026-03-31 $536,181 4,070
2025-12-31 $431,446 3,042
2025-09-30 $743,732 5,298
2025-06-30 $361,107 2,873
2025-03-31 $710,383 6,423
2024-12-31 $1,444,169 10,580
2024-09-30 $260,051 2,257
2024-06-30 $367,991 2,673
2024-03-31 $867,516 6,290
2023-12-31 $1,864,799 14,153
2023-09-30 $1,163,812 10,345
2023-06-30 $1,131,882 12,003
2023-03-31 $603,271 5,960
2022-12-31 $340,881 2,854
2022-09-30 $522,765 4,922
2022-06-30 $1,481,402 15,197
2022-03-31 $1,023,468 10,917
2021-12-31 $1,199,022 14,078
2021-09-30 $597,711 6,232
2021-06-30 $1,685,387 17,318
2021-03-31 $1,343,994 13,820
2020-12-31 $1,278,925 13,343
2020-09-30 $284,152 2,955
2020-06-30 $47,702 391
2020-03-31 $6,058 70